Andrew K. Chan serves as Executive at Cellular Biomedicine Group, Inc., where they oversee executive responsibilities. Since joining the company, Andrew K. Chan has executed 56 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 21, 2015 involved selling 1,516 shares valued at $31.5K.
Andrew K. Chan currently holds 239,747 shares of Cellular Biomedicine Group, Inc. (CBMG), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew K. Chan has been a net seller of CBMG stock. They have purchased $100.0K and sold $1.3M worth of shares.
Andrew K. Chan's most recent insider trade was on Sep 21, 2015, when they sold 1,516 shares at $20.80 per share.
Get notified when new Form 4 filings are submitted
| $20.80 |
| Discretionary |
| Oct 26, 2014 | CBMG | $0 | Other | 0 | $N/A | Discretionary |
| Sep 9, 2014 | CBMG | $0 | Other | 22,822 | $N/A | Discretionary |
| Jul 11, 2014 | CBMG | $0 | Other | 3,000 | $N/A | Discretionary |
| Mar 29, 2013 | CBMG | $0 | Other | 2,018 | $N/A | Discretionary |